Cargando…
Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
The high rate of mortality associated with ovarian cancer (OC) is due in part to the development of resistance to chemotherapy, which allows the resistant tumour cells to invade and metastasise. Clarifying the mechanistic basis for drug resistance may reveal novel avenues for treatment. The present...
Autores principales: | Zhang, Jin, Yuan, Baozhu, Zhang, Huidan, Li, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507388/ https://www.ncbi.nlm.nih.gov/pubmed/31186752 http://dx.doi.org/10.3892/ol.2019.10221 |
Ejemplares similares
-
The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects
por: Al-Qaissi, Ahmed, et al.
Publicado: (2019) -
PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019) -
Expression and Function of CD44 in Epithelial Ovarian Carcinoma
por: Sacks, Joelle D., et al.
Publicado: (2015) -
Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022) -
Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo
por: Fiedorowicz, M., et al.
Publicado: (2020)